Stimulation of anti-tumor immunity using dendritic cell/tumor fusions and anti-CD3/CD28.

被引：0
|
作者：
Rosenblatt, Jacalyn
Wu, Zekui
Lenahan, Corrine
Vasir, Baldev
Bissonnette, Adam
Kufe, Donald
Avigan, David
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3715.3715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3715
引用
收藏
页码：1061A / 1061A
页数：1
相关论文
共 50 条
  • [1] Stimulation of anti-tumor immunity using dendritic cell/tumor fusions and anti CD3/CD28
    Rosenblatt, J.
    Wu, Z.
    Lenahan, C.
    Vasir, B.
    Bisonette, A.
    Kufie, D.
    Avigan, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 69 - 70
  • [2] Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28
    Rosenblatt, Jacalyn
    Wu, Zekui
    Vasir, Baldev
    Zarwan, Corrine
    Stone, Richard
    Mills, Heidi
    Friedman, Thea
    Konstantinopoulos, Panagiotis A.
    Spentzos, Dimitrios
    Ghebremichael, Musie
    Stevenson, Kristen
    Neuberg, Donna
    Levine, James D.
    Joyce, Robin
    Tzachanis, Dimitrios
    Boussiotis, Vassiliki
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (02) : 155 - 166
  • [3] Adoptive immunotherapy using T cells stimulated by dendritic cell/tumor fusions and anti CD3/CD28
    Rosenblatt, Jacalyn
    Wu, Zekui
    Lenahan, Corrine
    Vasir, Baldev
    Bissonnette, Adam
    Ghebremichael, Musie
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 901 - 901
  • [4] T cell stimulation and expansion using anti-CD3/CD28 beads
    Trickett, A
    Kwan, YL
    JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 275 (1-2) : 251 - 255
  • [5] Coupling CD28 co-stimulation to IgTCR-mediated anti-tumor immunity: dynamics of tumor and T cell interactions
    Ripley, R
    Ma, J
    Safar, M
    Junghans, RP
    Beecham, EJ
    CANCER GENE THERAPY, 2001, 8 : S28 - S28
  • [6] CONTRIBUTION OF IMMUNOGENIC CELL DEATH (ICD) TO THE ANTI-TUMOR ACTIVITY OF CATUMAXOMAB (ANTI-EPCAM X ANTI-CD3)
    Goere, D.
    Flament, C.
    Chaput-Gras, N.
    Zitvogel, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 169 - 170
  • [7] ANTI-TUMOR IMMUNOTHERAPY WITH ANTI-CD3 MONOCLONAL-ANTIBODIES INDUCES A TUMOR SPECIFIC IMMUNE-RESPONSE
    ELLENHORN, JDI
    BLUESTONE, JA
    CLINICAL RESEARCH, 1989, 37 (02): : A408 - A408
  • [8] Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
    Pilon-Thomas, Shari
    Verhaegen, Monique
    Kuhn, Lisa
    Riker, Adam
    Mule, James J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (10) : 1238 - 1246
  • [9] Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
    Shari Pilon-Thomas
    Monique Verhaegen
    Lisa Kuhn
    Adam Riker
    James J Mulé
    Cancer Immunology, Immunotherapy, 2006, 55 : 1238 - 1246
  • [10] ACTIVATION AND EXPANSION OF TUMOR-INFILTRATING LYMPHOCYTES BY ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES
    NIJHUIS, EWP
    VANDERWIELVANKEMENADE, E
    FIGDOR, CG
    VANLIER, RAW
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 32 (04) : 245 - 250
12345